文献速递瓣膜外科先天性心脏病外科

婴儿二尖瓣Melody瓣膜置换术后感染性心内膜炎风险:法国经验

Risk of infective endocarditis after hybrid melody mitral valve replacement in infants: the French experience.
PubMed 文献 · Interdiscip Cardiovasc Thorac Surg · 2024-01-01

该回顾性队列报告法国7例危重婴儿接受Melody二尖瓣置换的经验,术后瓣膜功能良好且压差低,但6例出院患者中3例(50%)因确诊或高度怀疑感染性心内膜炎再入院,其中2例死亡。作者认为小瓣环婴儿可考虑该方案作为机械瓣替代,但晚期感染性心内膜炎高风险值得进一步考虑。

要点

  • 7例症状性婴儿(中位年龄3个月,体重4.3 kg)接受Melody二尖瓣置换,术后瓣膜功能良好、压差低(3 mmHg)。
  • 6例出院患者中3例(50%)因确诊或高度怀疑感染性心内膜炎再入院,其中2例死亡。
  • 作者认为小瓣环婴儿可考虑Melody二尖瓣置换作为机械瓣替代,但晚期感染性心内膜炎高风险值得进一步考虑。

核心结论

  • 作者认为,对于二尖瓣环较小的部分婴儿,可考虑Melody二尖瓣置换作为机械二尖瓣置换的替代方案。
  • 作者经验强调晚期感染性心内膜炎高风险,值得进一步考虑。

研究设计与样本

  • 回顾性队列研究,报告法国Melody二尖瓣置换经验,共纳入7例症状性婴儿。
  • 患儿年龄3个月(28天至8个月),体重4.3 kg(3.2-6.4 kg),二尖瓣环14 mm(11-16 mm)。
  • 病因包括完全性房室间隔缺损(n=4,其中唐氏综合征n=3)和吊床形瓣膜(n=3)。
  • 手术指征为重度二尖瓣反流(6例)或混合性瓣膜病变(1例)。

主要发现

  • 2例瓣膜被认为无法修复者直接行Melody二尖瓣置换,其余患者既往接受2次(1-3次)瓣膜修复尝试,3例在体外膜氧合支持下手术。
  • Melody二尖瓣置换后瓣膜功能良好,压差低[3 mmHg(1-4 mmHg)]。
  • 1例在植入后3天死于体外膜氧合相关卒中。
  • 6例出院患者中3例(50%)因确诊(1例)或高度怀疑(2例)感染性心内膜炎再入院,其中2例死亡。
  • 随访期间,1例在植入后9个月和16个月接受球囊扩张,2年时行机械二尖瓣置换;另1例目前计划行经导管Melody瓣膜扩张。

关键数值与推荐

  • Melody二尖瓣置换后压差为3 mmHg(1-4 mmHg)。
  • 6例出院患者中3例(50%)因确诊或高度怀疑感染性心内膜炎再入院,其中2例死亡。

临床怎么用

  • 作者认为,对于二尖瓣环较小的部分婴儿,可考虑Melody二尖瓣置换作为机械二尖瓣置换的替代方案。
  • 作者经验强调晚期感染性心内膜炎高风险,值得进一步考虑。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Surgical management of mitral valve disease is challenging in infants <1 year old. We aimed at reviewing the French experience with Melody mitral valve replacement in critically ill infants. METHODS: A retrospective cohort study reporting the French experience with Melody mitral valve replacement. RESULTS: Seven symptomatic infants [complete atrioventricular septal defect (n = 4, Down syndrome: n = 3), hammock valve (n = 3)] underwent Melody mitral valve replacement [age: 3 months (28 days to 8 months), weight: 4.3 kg (3.2-6.4 kg)] because of severe mitral valve regurgitation (6) or mixed valve disease (1) and 14 mm (11-16 mm) mitral valve annulus. In 2 patients whose valve was felt irreparable, Melody mitral valve replacement was performed straightaway. The others underwent 2 (1-3) previous attempts of valve repair; 3 were on extracorporeal membrane oxygenation. Melody mitral valve replacement led to competent valve and low gradient [3 mmHg, (1-4 mmHg)]. One patient died 3 days post-implant from extracorporeal membrane oxygenation-related stroke. Of the 6 discharged home patients, 3 (50%) were readmitted for a definite diagnosis (1) or high suspicion (2) of infective endocarditis, of which 2 died. Over the follow-up, 1 underwent balloon expansions of the valve at 9- and 16-months post-implant, and mechanical mitral valve replacement at 2 years; another is currently planned for transcatheter Melody valve dilation. CONCLUSIONS: Melody mitral valve replacement may be considered in selected infants with small mitral valve annulus as an alternative to mechanical mitral valve replacement. Our experience highlights a high-risk of late infective endocarditis that deserves further consideration.

来源:Interdiscip Cardiovasc Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Padovani P, Jalal Z, Fouilloux V, et al. Risk of infective endocarditis after hybrid melody mitral valve replacement in infants: the French experience. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38490258. doi:10.1093/icvts/ivae046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。